Sentinel Node Biopsy in Ductal Carcinoma in Situ: Is it Justifiable?

Background: For invasive breast cancer, sentinel node biopsy (SNB) is an acceptable alternative to axillary node clearance (ANC), although in the recent era, its role is under review. In ductal carcinoma in situ (DCIS), the benefit of SNB is even less well defined. Despite this, guidelines still rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Shurbasi, Nour, Hirst, Natalie A, Kohlhardt, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928077/
https://www.ncbi.nlm.nih.gov/pubmed/33680604
http://dx.doi.org/10.7759/cureus.13062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928077/
https://www.ncbi.nlm.nih.gov/pubmed/33680604
http://dx.doi.org/10.7759/cureus.13062

Ejemplares similares